ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      86.685
      -0.26%
      Bitcoin
      58,707.67
      -2.42%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Apellis Pharmaceuticals Inc (APLS)

      7. Apellis Pharmaceuticals Inc (APLS) Financials

      Apellis Pharmaceuticals Inc

      Apellis Pharmaceuticals Inc (APLS)

      Ls -1x Apple
      35.41
      0.43
      (1.23%)
      Closed July 04 4:00PM
      Delayed by 15 minutes
      35.41
      0.00
      (0.00%)
      After Hours: 5:00PM
      Delayed by 15 minutes

      Apellis Pharmaceuticals Inc Financial Summary

      The current APLS market cap is 4.3B. The company's latest EPS is USD -4.3309 and P/E is -8.18.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 44.85M94.97M110.4M146.38M172.33M
      Operating Income -175.08M-120.44M-137.08M-84.52M-62.09M
      Net Income -177.78M-122.04M-140.24M-85.58M-66.42M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0250.65M66.56M75.42M396.59M
      Operating Income -288.02M-213.73M-536.28M-594.61M-517.12M
      Net Income -304.71M-344.87M-746.35M-652.17M-525.63M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 978.87M915.58M818.22M788.73M831.93M
      Total Liabilities 566.75M570.18M585.95M594.21M565.25M
      Total Equity 412.12M345.4M232.27M194.52M266.68M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 389.25M960.57M881.77M760.22M788.73M
      Total Liabilities 355.02M756.01M683.1M590.35M594.21M
      Total Equity 34.23M204.56M198.66M169.87M194.52M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -177.62M-327.78M-496.86M-594.74M-132.98M
      Investing -259k-631k-678k-674k-293k
      Financing 391.11M392.67M398.41M394.5M108.21M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -211.14M-160.49M-563.13M-513.75M-594.74M
      Investing -1.69M-316.99M247.62M59.89M-674k
      Financing 388.54M692.18M392.24M365.66M394.5M

      Stats and Ratios

      Market Cap 4.3B
      Price to Earnings Ratio -8.18
      Price to Sales Ratio 10.84
      Price to Cash Ratio 12.24
      Price to Book Ratio 22.09
      Dividend Yield -

      Share Statistics

      Shares Outstanding 121.37M
      Average Volume (1 week) 2.07M
      Average Volume (1 Month) 1.42M
      52 Week Change -60.71%
      52 Week High 91.35
      52 Week Low 19.8301
      Spread (Intraday) 2.27 (6.09%)

      Company Info

      Company Name Apellis Pharmaceuticals Inc
      Address 108 lakeland ave
      dover, delaware 19901
      Website https://www.apellis.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NASDAQ
      APLS
      Apellis Pharmaceuticals
      Delayed Upgrade Clock